ProCE Banner Activity

Refining Therapeutic Approaches in R/R MM: Expert Guidance on Bispecific Antibody Therapy Optimization

Slideset

Enhance your understanding of how bispecific antibodies and combination therapies can be used to treat relapsed/refractory multiple myeloma by reviewing results from key clinical trials and learn how to better manage treatment-related adverse events.

Released: January 17, 2025

Expiration: January 16, 2026

Share

Provided by

Provided by the National Comprehensive Cancer Network in collaboration with Clinical Care Options, LLC.

ProCE Banner
ProCE Banner

Supporters

Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC. Supported by a grant from Pfizer Inc. Supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Pfizer, Inc.

Regeneron Pharmaceuticals, Inc